收费全文 | 1895188篇 |
免费 | 138244篇 |
国内免费 | 3446篇 |
耳鼻咽喉 | 27453篇 |
儿科学 | 60701篇 |
妇产科学 | 54027篇 |
基础医学 | 268706篇 |
口腔科学 | 56388篇 |
临床医学 | 165195篇 |
内科学 | 362580篇 |
皮肤病学 | 40482篇 |
神经病学 | 154398篇 |
特种医学 | 76500篇 |
外国民族医学 | 522篇 |
外科学 | 288924篇 |
综合类 | 47466篇 |
现状与发展 | 5篇 |
一般理论 | 642篇 |
预防医学 | 144326篇 |
眼科学 | 44929篇 |
药学 | 141245篇 |
47篇 | |
中国医学 | 3641篇 |
肿瘤学 | 98701篇 |
2018年 | 18402篇 |
2016年 | 16494篇 |
2015年 | 19209篇 |
2014年 | 25798篇 |
2013年 | 39194篇 |
2012年 | 53455篇 |
2011年 | 55537篇 |
2010年 | 32866篇 |
2009年 | 30539篇 |
2008年 | 53083篇 |
2007年 | 56856篇 |
2006年 | 57397篇 |
2005年 | 56283篇 |
2004年 | 55213篇 |
2003年 | 53106篇 |
2002年 | 51642篇 |
2001年 | 82559篇 |
2000年 | 84920篇 |
1999年 | 72379篇 |
1998年 | 20525篇 |
1997年 | 18693篇 |
1996年 | 18489篇 |
1995年 | 17747篇 |
1994年 | 16717篇 |
1993年 | 15764篇 |
1992年 | 59161篇 |
1991年 | 57533篇 |
1990年 | 56198篇 |
1989年 | 54268篇 |
1988年 | 50823篇 |
1987年 | 49798篇 |
1986年 | 47489篇 |
1985年 | 45924篇 |
1984年 | 34790篇 |
1983年 | 29970篇 |
1982年 | 18317篇 |
1981年 | 16528篇 |
1979年 | 34244篇 |
1978年 | 24125篇 |
1977年 | 20259篇 |
1976年 | 18920篇 |
1975年 | 20388篇 |
1974年 | 25125篇 |
1973年 | 23942篇 |
1972年 | 22388篇 |
1971年 | 21090篇 |
1970年 | 19698篇 |
1969年 | 18563篇 |
1968年 | 16957篇 |
1967年 | 15480篇 |
Material and Methods: This retrospective study included 365 eyes that underwent PK using corneas from 231 donors between June 2010 and June 2015. Patients were divided into three groups (group 1: primary endothelial diseases; group 2: iatrogenic endothelial disorders; and group 3: other pathologies with a healthy endothelium) according to PK indications. The primary outcome measure was corneal graft survival at the last visit (clear or opaque). Graft clarity was assessed using Kaplan–Meier survival analysis.
Results: The most frequent PK indication was keratoconus (KC) (20.5%) followed by pseudophakic bullous keratopathy (PBK) (18.9%). Donor age had a negative impact on endothelial cell density (ECD) measured by an eye bank specular microscope (p < 0.001). Median best-corrected visual acuity in logarithm of the minimum angle of resolution units increased from 2.1 to 0.8 at 1 year after PK (p < 0.001). The clear graft rate was 96.7% at year 1, 88.8% at year 2, and 85.5% at year 3. Overall graft survival was 84.9% during a median of 39 months (range: 24–79 months) of follow-up. A higher graft survival rate (67.2%) was observed in KC compared to PBK during 6 years (p < 0.001). Recipients younger than 50 years of age showed a better graft survival rate than those older than 70 years of age (p = 0.037). Donor ECD, time between excision and death, and preservation time had no significant effect on graft survival. Frequent graft rejection episodes (GREs) and additional procedures during surgery had a negative impact on graft survival (p < 0.001 and p = 0.014, respectively). A worse graft survival was observed in group 2 compared to groups 1 and 3 (p = 0.042).
Conclusions: Young recipient age and KC were associated with a better graft survival. Graft endothelial density and preservation time had no impact on graft survival. PBK, low vision at baseline and year 1, frequent GREs, and additional interventions during surgery had a negative impact on graft survivals. 相似文献
Aims
To obtain an overview of the management and outcomes of children aged 18 years or younger diagnosed with differentiated thyroid carcinoma of follicular cell origin across the UK, by collecting and analysing data from the limited number of centres treating these patients. This multicentre data might provide a more realistic perspective than single-institution series.Materials and methods
Six centres submitted data extracted from historical records on patients aged 18 years or younger, diagnosed between 1964 and 2017. The univariate and multivariable Cox proportional hazard model was used to identify potential predictors of progression-free survival, using national data as a control.Results
Data on 166 patients were available for analysis. Females (74%) were predominant, and the age ranged from 3 to 19 years at diagnosis, mean 14.1 years. Nodal metastases were present in 51%; 12% had distant metastases. After surgery, 95% received radioactive iodine (39% on more than one occasion) and 4% received external beam radiotherapy. With a median follow-up duration of 5 years, 69% are alive with no evidence of disease; 20% are alive with a raised thyroglobulin level as the only evidence of residual disease; 6% have residual structural disease detectable on imaging; 2% have died, from cerebral metastases.Conclusion
Despite most patients having advanced disease at presentation, outcomes are very good. A national prospective registry should allow systematic collection of good-quality data and may facilitate research to further improve outcomes. 相似文献- Download : Download high-res image (134KB)
- Download : Download full-size image